CIM

Last updated on: 29.09.2025

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

CIM is the acronym for: CTLA-4-Ig costimulation modulator. This term refers to a group that selectively boosts the CD28-mediated co-stimulation of naïve T lymphocytes. To date, abatacept is the only drug of this active group approved on the market that can be used to treat autoimmune diseases.

Last updated on: 29.09.2025